COO 453

‘Road to the Top’- Healthcare Leaders Special

The healthcare industry in India has grown by leaps and bounds over the past few decades and is now worth an estimated INR 2 lakh crores. With a blend of public and private facilities, healthcare in India is seeing a surge of world-class technologies making it one of the best healthcare industries in the world.

In this special feature, eHEALTH provides a glimpse of the jouneys of the stalwarts, who through their contributions have taken Indian healthcare to greater heights. The feature shares experiences and visions of these leaders and how they have inspired others to achieve the best for the Indian healthcare industry.

A Vijay Simha
Chief Operating Offi cer and Vice President
BPL Health Management Solutions Division

A Vijay Simha joined BPL in 2006 after completing his assignment with Unisantis SA, head quartered at Geneva, Switzerland, as the CEO of Europe and North America. He was involved in the development of a very specialised
optical component used in focussing X-rays which had applications in the characterisation of materials and its performance.

A family of products was also developed using the technology to perform non-destructive testing of aerostructures and civil structures, in the process control of materials, elemental analysis of materials as well as low dose medical imaging.

At BPL, the effort, the Health Management Solutions Division has focussed on are technologies and services that address the needs of the frontline and primary healthcare practitioners, point of care diagnostic devices and specifi c customised solutions for primary care. Its association with Welch Allyn USA complemented its range of specifi c diagnostic tools that enhance the effectiveness of diagnosis and treatment at the point of care.

As a company, BPL strongly advocates the need to implement effective screening of the population in order to reduce the morbidity and mortality which contributes to a much better quality of life. The spin off is also reduced cost of treatment and higher productivity of the nation. This can be achieved if the masses were provided with accessibility of these screening services, penetration of the primary healthcare infrastructure into the interiors and compliance to therapy, apart from awareness and education.

Being a stakeholder within this space, the businesses should be committed to providing a dependable support system to both the public health system and private practitioners so that they could carry on their mission without interruption as this costs lives, increased suffering and wasted money.

Ajay G Piramal
Chairman, Piramal Group

“Ajay G Piramal is the key person behind Piramal’s success in the healthcare space in India.”

Ajay G Piramal, the Chairman of Piramal Group, holds a Master in Management Studies from Jamnalal Bajaj Institute of Management Studies, University of Bombay and has done Advanced Management Programme from the Harvard Business School in 1992.

Mr Piramal’s vision is to make his group the most admired one, in the eyes of all its stakeholders including the customers, shareholders, employees, and the society.

Piramal Healthcare, a leading healthcare company, has had a growth record of 29 percent CAGR since 1988. Pharma Solutions, a division of Piramal Healthcare, is one of the world’s leading pharmaceutical manufacturing companies offering a unique full life cycle partnership and drug development services to small/virtual and big pharma companies. Piramal has also forayed into the life sciences segment recently and Piramal Life Sciences has a state-of-the-art R&D laboratory in Mumbai with over 300 scientists engaged in various drug discovery processes. The Piramal Group has a strong presence in the diagnostics market as well and owns India’s largest chain of clinical diagnostic centres.

Ajay G Piramal, one of India’s most dynamic business visionaries, has spearheaded the growth of this group and been the key person behind Piramal’s success in the healthcare space in India.

Ajay Pitre
Managing Director
Sushrut-Adler Group

“Ajay’s experience makes him believe that India has a phenomenal potential to be a global base for medical device innovations.”

Ajay Pitre, the Managing Director of Sushrut-Adler Group, has played an instrumental role in the growth and development of the indigenous medical equipment industry for over two decades now. Sushrut Group has a presence throughout India with a network of more than 140 distributors. Apart from India, the Group operates in 28 other countries.

Ajay’s experience in the Indian medical device market makes him believe that India has a phenomenal potential to be a global base for medical device innovations. Acknowledging his contribution to the Indian orthopaedic industry, he was honoured with the ‘Certifi cate of Excellence’ by the Indian orthopaedic association in 2003.

Ajay is a member of the FICCI Medical Device Forum and Vice President of the CII MLED. He is also a member of the core committee advising the government on the formation and implementation of the Medical Devices Regulation standards in India

Ajay’s expertise and dedication are probably the most important reasons for the leadership position the Sushrut-Adler group enjoys in the Indian market today, a fact that has been confi rmed externally through a survey by Datamonitor (a Reuters Group Company), an international rating agency in 2002. All this has been possible under the able leadership of Mr. Pitre.

Analjit Singh
Founder & Chairman
Max India Ltd.

“Analjit Singh has spearheaded the sustained growth and success of the Max India Group”

Analjit Singh has spearheaded the sustained growth and success of the Max India Group that includes Max Healthcare Institute Ltd—one of the leading chain of hospitals in India. Max Healhcare comprises of over 800 beds and 8 hospitals in Delhi, 1500 physicians and 3000 support staff. With state-of-the art infrastructure and 225 ICU beds Max ranks among the best hospitals in the country.

Anajit’s dream to bring service excellence to the country made him plunge into the hospitals and life insurance industries and he has excelled in these fi elds. An alumnus of Doon School, Dehradun; Shriram College of Commerce, University of Delhi; School of Management and the Graduate School of Management, Boston University, Boston, USA, Analjit is a self-made entrepreneur and one of India’s leading business persons. In addition to the Max Hospitals, Max Group includes Max Bupa, a health insurance company and Max Neeman, a clinical research organisation; in the healthcare space.

Under the dynamic leadership of Analjit, Max Healthcare envisions to deliver world-class healthcare with a service focus by creating an institution committed to the highest standards of medical & service excellence, patient care, scientific knowledge and medical education. The company aims to create unparalleled standards of medical and service outcome.

Anjan Bose
Senior Director & Business Head – Indian Sub Continent
Philips Healthcare

“Anjan through his expertise has brought the latest and best medical technologies to the country. ”

An Electronics and Electrical Communication Engineer from Indian Institute of Technology, Anjan Bose began his career as a Service Engineer at Philips Medical almost three decades back.

Throughout his journey, he has been actively involved in shaping Philips Healthcare’s stand in the Indian sub continent and has been involved in several important functions within the healthcare industry.

During his career with Philips, Anjan has also worked in Europe as a Regional Manager and at Philips Headquarters in Holland. Apart from Philips, Anjan has also worked with Hewlett Packard Medical in South Asia and Emerging Markets in Asia.

A Council Member of the European Business Group, Anjan, in the past, has also been the Chairman of the Medical Equipment Forum of Federation of Indian Chambers of Commerce and Industry (FICCI) and the Co-Chairman of its Health Services Committee.

As a part of one of the leading medical equipment vendors in the world, Anjan through his expertise has brought the latest and best medical technologies to the country. He has played a key role in shaping the medical technology of the Indian healthcare industry.

Anjan Bose has the overall responsibility for leading the entire operations in this region and to ensure the market leadership, signifi cant growth and customer delight for all the Medical Systems businesses.

Dr. Arjun Kalyanpur
CEO
Teleradiology Solutions

Dr. Arjun Kalyanpur, the pioneer of teleradiology in India, completed his medical education at India’s premier medical school AIIMS, New Delhi followed by postgraduation in Diagnostic Radiology leading to the MD degree, also at the AIIMS. In 1992, Dr Kalyanpur moved to the US where he obtained fellowship training in Body Imaging at the Cornell University Medical Center in New York and in Neuroradiology at the Yale University School of Medicine, New Haven, Connecticut and also became certifi ed by the American Board of Radiology. Dr Kalyanpur then worked on the Clinical Faculty of Yale University before returning to India in 1999.

In 2002, he set up Teleradiology Solutions, a one-ofits-kind health care IT company that today provides teleradiologic interpretations to over 100 hospitals in the US, Singapore, Europe and now in remote areas of India. Teleradiology Solutions (US) is accredited by the US Joint Commission for Accreditation of Healthcare Organizations. It is also the fi rst organization outside Singapore to be accredited by the Ministry of Health, Singapore. Through its Telerad Foundation it provides high quality telediagnostics to remote parts of India. Through its teaching website www.radguru. net, it provides a valuable online teaching resource to radiologists globally. A state-of-the-art training center, Radgurukul has been created to deliver regular updates to radiologists and technologists in the form of conferences, with international videopresence. Its technology division, Teleradtech has developed a cutting edge radiology workfl ow platform RadSPA. This has been made possible in part by the drive and initiative of Teleradiology’s CEO, Dr Kalyanpur. Dr Kalyanpur has been featured several  years in succession in Who’s  ho in the World and Who’s Who in Medicine. He has also been featured on, among other places, ABC, NBC, CBS, the New York Times and the New England Journal of Medicine as the path breaking pioneer of teleradiology services in Asia.

Brig. (Hony. ) Dr. Arvind Lal
Chairman and Managing Director
Dr. Lal PathLabs Pvt. Ltd.

Brig. (Hony.) Dr. Arvind Lal is the Chairman and Managing Director of Dr. Lal PathLabs, which is one of the best pathology laboratory chains in India. Taking over Dr. Lal PathLabs in 1977, Dr. Arvind Lal brought about complete modernisation of the laboratories keeping in mind the emerging global trends in laboratory medicine. He is recognised as a pioneer in bringing laboratory services in India at par with the western world.

In July 2009, Dr Lal was accorded with the honorary rank of Brigadier in the Armed Forces Medical Services by the Hon’ble President of India. In the same year, Dr. Arvind Lal was also conferred with the prestigious ‘Padma Shri’ award recognising his excellent work in bringing up laboratory medicine in the Indian healthcare sector. In addition, Dr. Lal has won several awards and honours including the ‘Delhi Ratna’ award; ‘Indira Gandhi Solidarity’ award; and ‘International Business Council’ award, among others. In 2001, Dr Arvind Lal was appointed as the Honorary Physician to the President of India.

Dr. Arvind Lal has taken Dr. Lal PathLabs to greater heights making it one of the most reputed laboratories in Asia with the highest number of accreditations (eight) from the National Accreditation Board for Testing and Calibration Laboratories. The laboratory is also internationally recognised in the form of accreditation from the College of American Pathologists (CAP – USA). The lab currently tests more than 12,000 patients a day in its 60 labs all over India.

Dr. Lal is credited with introducing several news tests, instruments and technologies, and ICT implementation in laboratory medicine. The R&D unit under Dr. Lal PathLabs is recognised by the Department of Science and Technology and thus provides highly specialized tests at low cost to the weaker sections of the society.

Dr. Ashok Kumar
Dy. Director General
Central Health Services (CHS), Govt. of India

Dr. Ashok Kumar has been a part of several programmes/ initiatives including Global Smallpox Eradication; ICMR’s research on Cholera; preventive and social medicine teaching at Institute of Medical Sciences, Varanasi and MAMC, New Delhi; research and teaching on Leprosy and its eradication, directing National Leprosy Eradication Programme; research and teaching on Lymphatic Filariasis and Intestinal Parasitic Infections; eradication of Guinea Worm disease; National TB Control and Mental Health; MCH/Reproductive & Child Health; Malaria and

Other Vector borne diseases control; health promotion & education; Public Health (Prevention of Food Adulteration Act); and Health Intelligence and Family of International Classification (FIC – ICD, ICF & ICHI) related activities and consultancies at national & international levels since January 2004.

He has won several awards that recognise his work in the health sector including WHO and GOI Meritorious Service Certifi cate for Global Small Pox Eradication; WHO Fellowship; Technical Focal Point for SAARC TB Control in India; Led High Level Indian Delegation to the First World Congress on Maternal Mortality, Marakesh, Morroco; The President Carter (USA) Award for Guinea Worm Disease Eradication from India; Indian Association of Epidemiologists Honour Certifi cate for Guinea Worm Disease Eradication from India, by Hon’ble Minister of Health & FW, Govt. Of India; Meritorious Service Award 2002 for contributions towards leprosy elimination by Hon’ble Lt. Governor of Delhi; Dr B C Das Gupta Oration Award, Indian Public Health Association; and Golden Jubilee Award, Indian Public Health Association (IPHA).

He has more than 120 publications in various national/international journals and has contributed in more than 300 conferences/seminars/symposia and workshops at national and international levels.

Dr. Ashok Seth
Chairman – Cardiac Sciences
Escorts Heart Institute & Research Centre

Dr. Ashok Seth, an internationally renowned cardiologist, has contributed extensively to the growth, development and scientifi c progress of Cardiology especially Interventional Cardiology in India and across the world. Over the past 20 years he has pioneered numerous angioplasty techniques for India and Asia Pacifi c region. His pioneering efforts in angioplasty have won him respect and accolades all across the world.

His efforts have created a unique respect for India on the international sphere especially in the West. For his unique achievements and contributions he was honoured by the National award of ‘PADMA SHRI’ by the President of India in 2003. Dr. Seth has performed one of the higest number of angiographies and angioplasties in the world – which is acknowledged by the ‘LIMCA‘ Book of Records.  Dr. Seth has the unique honor to be invited to demonstrate and teach complex angioplasty techniques via the satellite transmission from New Delhi to the ‘Transcatheter Cardiovascular Therapeutics in 2003 & 2007’ Meeting in Washington DC (USA) and to EuroPCR in Paris in 2006 (from Bangkok) & in 2003 (from Chennai), which are the most important and biggest meetings of Interventional Cardiologists across the World.

Dr. Seth has had the unique distinction to be elected on the Board of Governors of Society of Cardiac Angiographies and Intervention (USA). This is a fi rst for any cardiologist from Asia. Dr. Seth is setting up a Foundation in association with patients of heart disease (Prem Lata Foundation – Dil Se Dil) to further the cause of those suffering from heart disease. This foundation aims to prevention in of heart disease, patient education, activities to raise fund for poor patients and forums and activities to decrease the cost of heart care in this country. It also targets burning issues like “awareness of heart disease in women” as well as “valve disease in poor patients in villages”.

Babu A
Chief Executive Offi cer, Aarogyasri Health Care Trust

Under Mr Babu A’s leadership the unique health insurance scheme ‘Rajiv Aarogyasri Community Health Insurance Scheme’, transformed the health care scenario in AndhraPradesh. He has established an online process fl ow for tracking patients from the point of screening in the villages, reporting to hospitals, treatment, discharge, follow-up and fund management thus making the scheme work on a paperless platform with accountability. The other salient features of the scheme include universal coverage, identifi ed packages, cashless diagnostics and treatment, health camps, Aarogyamithras (Patient facilitators), etc. The scheme is being run under a Public-Private-Partnership that includes a private insurer, public and private hospitals, women’s self-help groups and the state government. There are strict protocols on the treatment, with 942 medical and surgical packages listed and the costs fi xed by the trust’s panel of doctors. Since inception of the scheme 17,338 medical camps were held by the network hospitals in rural areas and 30.28 lakh patients were screened in these health camps. So far 9.36 lakh patients were treated as outpatients and 6.68 lakh patients treated as in-patients in 350 network hospitals under the scheme. 5.76 lakh patients underwent surgery / therapy and the amount preauthorized for the same is Rs 1704.29 crores.

Babu A completed MSc (Agriculture) from Indian Agricultural Research Institute with specialization in Agricultural Extension and BSc (Agriculture) from College of Agriculture, Vellayani, Trivandrum, Kerala Agricultural University. He has a vast experience, which includes being the Manager, National Bank for Agriculture & Rural Development, Bhopal; Indian Revenue Service; Assistant Commissioner (Customs & Central Excise); Assistant Collector, Guntur, Andhra Pradesh; Indian Administrative Service; and Sub Collector, Madanapally, Chittoor, AP.

1 Comment

1 Comment

  1. Pingback: van cleef alhambra braccialetto oro imitazione

Leave a Reply

Your email address will not be published.

Most Popular

 

 

 

 

 

Get Heard Portal

 

eHealth Event Report

 

 

To Top